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Effect of renal center characteristics on mortality and tech- patient outcomes. Many changes to PD have occurred
nique failure on peritoneal dialysis. since the technique’s inception, including several techni-
Background. Recent studies report decreased mortality in cal advancements and changes in patient managementpatients on peritoneal dialysis (PD) over time, suggesting that
strategies [6–9]. Recent reports indicate that PD mortal-advances in PD have resulted in improved patient outcomes.
ity is decreasing in North America [10, 11] and that tech-Our investigation sought to assess the effect of renal center
characteristics on mortality and technique failure (TF) rates. nique failure (TF) rates have decreased in Canada [12],
Methods. Covariates of interest included center-specific cu- suggesting that the enhancements to PD indeed are re-
mulative number of PD patients treated, percentage of patients sulting in improved patient outcomes.who initiated dialysis on PD, and academic status. Using data
It is reasonable to hypothesize that PD mortality andobtained from the Canadian Organ Replacement Register, the
TF rates are not constant across renal centers. Character-17,900 patients who received PD during the 1981 to 1997 period
were studied. Mortality and TF rate ratios (RR) were estimated istics such as a center’s experience in PD delivery, em-
using Poisson regression, adjusting for age, gender, race, pri- phasis placed on PD relative to HD, and academic status
mary renal diagnosis, province, follow-up time, and type of PD. may well affect patient outcome. Since very few studiesResults. As the cumulative number of PD patients treated
have examined the effect of renal center characteristicsincreased, covariate-adjusted mortality significantly decreased
on PD mortality and TF rates, the objective of our inves-(P  0.05); a weaker yet significant association was observed
between number of PD patients treated and TF. As the percent- tigation was to assess these associations using a nation-
age of patients initiating dialysis on PD increased, TF rates wide organ failure database.
decreased significantly. No association was observed between
center academic status and PD mortality or TF rates.
Conclusions. These results imply that a center’s experience METHODS
with and degree of specialization toward PD impact strongly
Data were obtained from the Canadian Organ Replace-on PD outcomes. One hypothesis is that a center’s propensity
ment Register (CORR) of the Canadian Institute forto exploit technical and non-technical advances in PD increases
directly with these variables. It is also possible that, through Health Information (CIHI), a population-based, nation-
experience, centers become more adept at identifying appro- wide organ failure registry [13]. Baseline demographic
priate patients to receive PD. More detailed research is re- data are collected by each of the 86 renal centers from all
quired to evaluate these hypotheses.
patients at renal replacement therapy (RRT)-initiation,
including date of birth, gender, province of residence,
race and primary renal diagnosis (PRD). Patient-specificRecently, much research has been devoted to compar-
treatment history data are submitted annually by each cen-ing mortality in patients on peritoneal dialysis (PD) and
ter, including dialytic modality assignments and switches,hemodialysis (HD) therapy [1–5]. However, it also is
transplantations, and graft failures. Date and cause of
useful to observe PD in isolation over a broad period of
death, where applicable, are reported along with the other
time to examine trends and determine factors affecting
follow-up information. Data were available on all pa-
tients initiating therapy between January 1, 1981, and De-
cember 31, 1997. Beginning in 1988, CORR began collect-Key words: center effect, end-stage renal disease, renal failure, survival
and dialysis, renal replacement therapy, Canadian kidney statistics. ing information on predialysis comorbid conditions for all
incident patients. Data were available on cardiovascularReceived for publication May 2, 2000
disease (that is, symptomatic angina, acute myocardialand in revised form May 23, 2001
Accepted for publication May 29, 2001 infarction, pulmonary edema, cerebrovascular accident,
and peripheral vascular disease), chronic obstructive lung 2001 by the International Society of Nephrology
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Table 1. Baseline characteristics of patients initiating peritonealdisease, malignancies, and any “other serious illnesses”
dialysis (PD) 1981–1997
(that is, diseases expected to greatly reduce 5-year sur-
Characteristica N %bvival probability, but not falling cleanly into each of the
Age group yearslisted categories; for example, HIV infection).
0–14 487 2.7The study population included the 17,900 patients who
15–44 4,421 24.7
received peritoneal dialysis between January 1, 1981, and 45–64 6,614 36.9
65 6,378 35.6December 31, 1997. Each patient’s follow-up time on
GenderPD was computed. Patients were classified by gender,
Female 7,840 43.8
PRD, and race (black, Caucasian, Aboriginal Canadian, Male 10,058 56.2
Unknown 2 0.0Asian, East Indian, and other/unknown). Person years
Race(PY) of follow-up among patients receiving PD were
Black 432 2.4
classified by age (14, 15 to 44, 45 to 64, 65 to 74, 75), Caucasian 14,367 80.3
Aboriginal Canadian 687 3.8calendar period (1981 to 1985, 1986 to 1989, 1990 to
Asian 910 5.11993, 1994 to 1997), follow-up time (1-year intervals) and
East Indian 421 2.4
type of PD [continuous ambulatory/cyclic PD (CAPD/ Other/unknown 1,083 6.1
Calendar PeriodCCPD), intermittent PD (IPD)]. Of course, age, calendar
1981–85 3,519 19.7time, follow-up interval, and PD type were dynamic vari-
1986–89 3,626 20.3
ables in that patients could contribute PYs to more than 1990–93 5,227 29.2
1994–97 5,528 30.9one category as they progressed through the period of
Primary renal diagnosisobservation.
Diabetes 4,964 27.7
With respect to renal center, patients were assigned Glomerulonephritis 2,865 16.0
Polycystic kidneys 857 4.8to the center at which they first received PD. Three
Renal vascular 2,850 15.9covariates were used to characterize centers: (1) cumula-
Other 6,364 35.6
tive number of patients treated with PD, (2) percentage
Total 17,900 100of patients who received PD (%PD) among those initiat-
a Patients classified based on date of PD initiationing chronic dialysis, and (3) academic status. The “cumu- b Percentages may not add to 100.0 due to rounding
lative PD patient count” variable was intended to repre-
sent the experience of each renal center with peritoneal
dialysis, while the “% PD” variable was intended to
reflect degree of specialization towards PD relative to similarly, except that patients were censored after their
first TF (that is, switch from PD to HD) since subsequenthemodialysis. These two center-specific variables, for
each patient, were computed based on the experience TF’s for the same patient would be dependent. Poisson
at the center up to and including the patient’s year of regression [14, 15] was used to compare rates among the
PD initiation. For example, consider a patient who re- categories of cumulative PD patient count, % PD, and
ceived PD for the first time at center 4 in 1991. The academic status covariates while adjusting for age, gen-
cumulative PD patient count variable would be com- der, race, province, PRD, calendar period, follow-up in-
puted as the total number of patients who received PD terval, and type of PD. The rate ratio (RR, that is, rate
at center 4 between 1981 and 1991. The % PD variable for each renal center category, relative to the arbitrarily
would be calculated as follows: nPD (nPD nHD) 100%, chosen reference category) served as the parameter of
where nPD denotes the just-described cumulative PD pa- interest.
tient count, summed over years 1981 through 1991 inclu-
sive, and nHD is defined analogously for hemodialysis.
RESULTSCumulative PD patient count was divided into six catego-
In Table 1, baseline demographic and clinical charac-ries: 99, 100 to 199, 200 to 299, 300 to 399, 400 to
teristics are listed for patients who initiated PD in Can-499, and 500. The % PD variable was subdivided into
ada during the 1981 to 1997 period (N  17,900). Ap-19%, 20 to 29, 30 to 39, 40 to 49, 50 to 59, and 60%.
proximately 37% of patients were in the 45 to 64 ageCenters were classified as academic or nonacademic,
group upon PD initiation, while about 36% were agedbased on whether they were directly affiliated with a
65 years. The male:female ratio was approximatelymedical school.
56:44. Eighty percent of PD patients were Caucasian,Mortality rates were computed as the ratio of deaths
while the second most frequent race was Asian (5%).to person-time on PD. With respect to mortality, an “as-
Aboriginal Canadians comprised less than 4% of thetreated” analysis was performed, wherein patients were
study population. Great increases in the number of PDfollowed after switching modalities, with deaths were
patients occurred over calendar time, as over 60% ofattributed to the dialytic modality received at the time
of death. Technique failure (TF) rates were computed the study population was composed of patients who initi-
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Fig. 1. Distribution, by center, of cumulative
number of peritoneal dialysis (PD) patients as
of December 31, 1997.
ated PD after January 1, 1990. Among the specified and ence between the unadjusted and adjusted RRs, and little
difference between RRs adjusted for all covariates exceptknown PRDs, diabetes was the most common at 28%.
The frequency distribution by center of cumulative other center characteristics (that is, cumulative PD pa-
tient count, academic status) and those adjusted for allnumber of patients treated with PD (as of December 31,
1997) is presented in Figure 1. Approximately 46% of covariates including other center characteristics.
Crude death rates showed practically no trend acrosscenters had treated less than 100 registered patients with
PD, while 19% had treated between 100 and 199. One %PD categories (Table 2), with unadjusted RR 1 for
all nonreferent categories. Upon adjustment for all co-center had treated over 900 registered PD patients dur-
ing the period of observation. variates except other center characteristics, RRs for all
%PD categories were strongly elevated relative to theThe distribution by center of the fraction of patients
initiating dialysis on PD is depicted in Figure 2. At 17% reference level (60% of patients initiating RRT on PD),
with partially adjusted RRs ranging from 1.17 to 1.23.of Canadian centers, PD was offered as an initial mode
of dialysis to less than 10% of patients. For slightly less However, upon adjustment for center-specific cumula-
tive PD patient count and academic status, RRs werethan one fifth of centers, the percentage of patients ini-
tiating dialysis on PD was greater than 50%. More than greatly reduced for each category. Covariate-adjusted
RRs were still significantly increased for the 40 to 49%90% of patients initiated dialysis on PD at only 5% of
centers. and 50 to 59% categories; no dose-response relationship
was apparent between the fraction of patients initiatingCategory-specific mortality rates and rate ratios are
listed in Table 2 for each renal center characteristic. RRT on PD and covariate-adjusted mortality.
Unadjusted PD mortality rates per 1000 were 212.7Overall, there were 6,269 deaths during the 33,937 PYs
of observation on PD, for an unadjusted mortality rate for and 177.1 for nonacademic and academic centers,
respectively (Table 2). Upon adjustment for all covari-of 184.7 deaths per 1000 PYs. Unadjusted and adjusted
mortality rates decreased in a monotone fashion as the ates except other center characteristics (%PD, cumula-
tive PD patient count), the RR increased from 0.84 tototal number of PD patients treated increased. In fact,
statistically significant (P  0.05) reductions in adjusted 0.97; upon adjustment for other center characteristics,
the RR rose to 1.07 (1.00, 1.14), barely failing to attainmortality were observed for all cumulative PD patient
groupings (relative to the reference category: 99 pa- statistical significance.
Technique failure rates and rate ratios by center char-tients) except in the 100 to 199 patient category. Unad-
justed mortality rates ranged from 202.7 in the 99 pa- acteristic are presented in Table 3. In total, there were
5,956 first TFs over 31,919 PY of observation for antient category down to 138.9 in the 500 group. For
centers where at least 500 registered PD patients had overall TF rate of 186.6 per 1000 PYs. Unadjusted TF
rates decreased monotonically from 202.7 (99 patients)been previously treated, adjusted mortality was 29% less
(RR  0.71), relative to that for centers wherein 99 to 138.9 (500 patients) per 1000. Generally, covariate-
adjusted RRs decreased as the center-specific total num-patients had ever been treated. There was little differ-
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Fig. 2. Distribution, by center, of percentage
of patients initiating dialysis on peritoneal di-
alysis (PD), as of December 31, 1997.
Table 2. Peritoneal dialysis (PD) mortality rates and rate ratios by center characteristic
Unadjusted Partially Covariate-adjustede
mortality rate Unadjusted adjusted
Characteristica Deaths PYb per 1,000 RRc RRd RR 95% CIf
Cumulative number of PD patients treatedg
99 2,094 10,328 202.7 1 1 1 —
100–199 1,435 7,176 200.0 0.99 0.96 0.95 0.88–1.03
200–299 969 5,076 190.9 0.94 0.89 0.87 0.79–0.97
300–399 595 3,352 177.5 0.88 0.87 0.85 0.75–0.95
400–499 430 2,635 163.2 0.81 0.83 0.80 0.70–0.91
500 746 5,369 138.9 0.69 0.72 0.71 0.63–0.81
Percentage of patients initiating dialysis on PDh
29% 685 3,695 185.4 0.98 1.23 1.06 0.94–1.20
30–39% 1,597 9,492 168.2 0.89 1.23 1.09 0.98–1.21
40–49% 1,399 7,460 187.5 0.99 1.22 1.12 1.02–1.23
50–59% 1,261 6,284 200.7 1.06 1.17 1.11 1.02–1.20
60% 1,327 7,006 189.4 1 1 1 —
Center academic status
Non-academic 1,552 7,296 212.7 1 1 1 —
Academic 4,717 26,641 177.1 0.84 0.97 1.07 1.00–1.14
Total 6,269 33,937 184.7
a Patients were classified based on the center at which PD was initiated
b PY, patient-years of follow-up on PD
c RR, ratio of category-specific rate to rate for reference category
d RR, estimated using Poisson regression and adjusted for age, gender, race, province, primary renal diagnosis, calendar period, follow-up time and type of PD
(i.e., CAPD/CCPD, IPD), but not other center characteristics
e RR, estimated using Poisson regression and adjusted for other center characteristics in addition to all other covariates listed in footnoted
f CI  confidence interval
g Number of patients ever receiving PD at that center up to and including the year of RRT-initiation
h Based on all years up to and including the year of PD-initiation, for each patient; fraction  PD/(PD  HD)  100%
ber of PD patients increased, the reduction attaining Based on Table 2, the total number of PD patients
treated appears to have a strong and significant effectstatistical significance for all categories except the 100 to
199 patient category. Covariate-adjusted RRs decreased on mortality; the same can be said with respect to TF
for the percentage of patients initiating dialysis on PD.strongly as the percentage of patients beginning on PD
decreased, with RR  1.75 (1.54, 1.98) for centers in The robustness of each of these effects is examined sepa-
rately in Table 4, where results based on 1981 to 1997the 29% category relative to those in which 60% of
dialysis patients began on PD. There was no difference and 1990 to 1997 patients are compared. Regarding mor-
tality, the effect ranged from RR  0.95 (100 to 199between academic and nonacademic centers with respect
to covariate-adjusted TF rates (RR  0.98). patient category) down to RR  0.71 (500 category),
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Table 3. Peritoneal dialysis (PD) technique failure (TF) rates and rate ratios by center characteristic
Unadjusted Partially Covariate-adjustede
mortality rate Unadjusted adjusted
Characteristica TF PYb per 1,000 RRc RRd RR 95% CIf
Cumulative number of PD patients treatedg
99 1,889 9,460 199.7 1 1 1 —
100–199 1,333 6,683 199.5 1.00 1.00 0.97 0.89–1.05
200–299 865 4,689 184.5 0.92 0.92 0.89 0.80–0.99
300–399 543 3,226 168.3 0.84 0.84 0.81 0.71–0.91
400–499 453 2,570 176.3 0.88 0.88 0.82 0.72–0.94
500 873 5,284 165.2 0.83 0.83 0.83 0.73–0.95
Percentage of patients initiating dialysis on PDh
29% 707 3,690 208.5 1.44 1.97 1.75 1.54–1.98
30–39% 1,656 8,722 189.9 1.31 1.70 1.58 1.42–1.76
40–49% 1,391 7,009 198.5 1.37 1.71 1.64 1.48–1.80
50–59% 1,216 6,974 203.6 1.41 1.44 1.41 1.29–1.54
60% 986 6,818 144.6 1 1 1 —
Center academic status
Non-academic 1,398 6,846 204.2 1 1 1 —
Academic 4,558 25,067 181.8 0.89 0.88 0.98 0.92–1.06
Total 5,956 31,913 186.6
a Patients were classified based on the center at which PD was initiated
b PY, patient-years of follow-up on PD
c RR, ratio of category-specific rate to rate for reference category
d RR, estimated using Poisson regression and adjusted for age, gender, race, province, primary renal diagnosis, calendar period, follow-up time and type of PD
(i.e., CAPD/CCPD, IPD), but not other center characteristics
e RR, estimated using Poisson regression and adjusted for other center characteristics in addition to all other covariates listed in footnoted
f CI  confidence interval
g Number of patients ever receiving PD at that center up to and including the year of RRT-initiation
h Based on all years up to and including the year of PD-initiation, for each patient; fraction  PD/(PD  HD)  100%
displaying a monotone dose-response relationship for (99 PD patients ever treated) to RR  0.71 (500
patients). A statistically significant but weaker associa-1981 to 1997 patients. The trend is preserved when only
tion was observed between number of PD patients1990 to 1997 patients are considered; however, the effect
treated and technique failure. As the percentage of pa-is more marked, ranging from RR  0.81 (100 to 199
tients initiating dialysis on PD increased, TF rates de-patients) to 0.54 (500 category). For 1990 to 1997 pa-
creased significantly, with RR  1.75 for centers withtients, the effect changed little upon adjustment for co-
29% (relative to 60%) of patients beginning on PD.morbid conditions and decreased slightly for categories
No association was observed between center academicwhere they did differ, ranging from RR  0.78 (100 to
status and PD mortality or TF rates.199 patients) down to RR  0.51 (500 patients), with
Among outcomes, mortality on PD was our chief inter-statistical significance attained for all non-referent cate-
est. Rates of TF were examined because they were alsogories. Regarding TF, the effect based on 1981 to 1997
of interest; but also, since mortality and TF “compete”patients (Table 3) ranged from RR  1.44 (50 to 59%
with each other (that is, a patient cannot be counted aspatients beginning on PD) to RR  1.97 (29%). This
both a TF and a death), a covariate’s effect on mortalityeffect was maintained and only slightly dampened by con-
is of limited interpretability unless its effect on TF issidering only 1990 to 1997 patients, ranging from RR 
assessed also. It could be hypothesized that the decrease1.30 (50 to 59% PD) to RR  1.67 (29%). Within the
in mortality with increasing number of PD patients1990 to 1997 cohorts, covariate and covariate/comorbid-
treated could be the result of high PD use centers beingity effect estimates for TF were identical.
more likely to switch their patients off PD to HD. TheNote that no discernible trends across center charac-
same argument could be made against %PD as an initialteristics were observed when mortality and TF rates were
dialytic modality. However, the fact that adjusted TFexamined by cause of death or when specific patient
rates also were found to decrease significantly offerssubgroups were examined.
strong evidence against this hypothesis.
The as-treated method of analysis was used through-
DISCUSSION out this investigation, wherein patients contribute PD
As the cumulative number of PD patients treated by a patient time and events only while they are receiving PD.
center increased, covariate-adjusted mortality decreased However, the magnitude of our findings is not related
(P  0.05); a smooth dose-response relationship was to our arbitrarily chosen method of analysis. The most
sophisticated means of handling TF when examiningobserved across the six categories ranging from RR  1
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Table 4. Rate ratios based on 1990–97 experience and adjusted for comorbidity
1981–97 1990–97
1990–97 Covariate- and
Outcome Characteristic comorbidity-adjusted RR 95% CICovariate-adjusted RR
Mortality Cumulative number of PD patients treated
99 1 1 1 —
100–199 0.95 0.81 0.78 0.67–0.91
200–299 0.87 0.73 0.71 0.60–0.84
300–399 0.85 0.69 0.69 0.57–0.83
400–499 0.80 0.66 0.63 0.51–0.78
500 0.71 0.54 0.51 0.41–0.64
Technique failure Percentage of patients initiating dialysis on PD
29% 1.97 1.67 1.67 1.34–2.07
30–39% 1.70 1.65 1.65 1.38–1.98
40–49% 1.71 1.59 1.59 1.35–1.88
50–59% 1.44 1.30 1.30 1.11–1.52
60% 1 1 1 —
mortality was described in a recent paper by Collins et prior to January 1, 1981 would not be included. However,
the goal was not to count the number of exact numberal [3]. Here, PD patients were censored 60 days following
a modality switch, with deaths during the 60-day window of patients, per se; but to assign the centers to ordered
categories. Thus, to the extent that the observed orderingattributed back to PD. As an example, when we adopted
these methods, the mortality RR’s for cumulative PD based on registered patients is appropriate, centers were
classified correctly. We detected statistically significantpatient count actually decreased (for example, RR 
0.64 for 500 patients compared with RR  0.71 in associations between cumulative PD count and covariate-
adjusted mortality and TF. If misclassification occurredTable 2), indicating a strengthening of the effect.
It was postulated a priori that mortality and TF rates with respect to the ordered categorization of the center-
specific numbers of PD patients treated, provided it arosewould decrease with the number of PD patients pre-
viously treated, with the degree of specialization towards independently of outcome (that is, termed “non-differen-
tial misclassification” by epidemiologists [16]), it wouldPD, and among academic renal centers. Hemodialysis
has been available more than 20 years longer than PD, have served to bias the RRs toward 1, and, hence resulted
in our underestimation of the impact of a center’s PDand the latter was once considered by many nephrolo-
gists as an inferior form of dialysis. It is possible that experience on mortality.
The %PD variable represents an attempt to quantifynephrologists from centers where a relatively large num-
ber of PD patients have been treated were more aggres- each center’s degree of specialization towards PD rela-
tive to hemodialysis. A possible source of misclassificationsive in terms of exploiting the numerous advances to
patient management since the inception of the modality arises from the fact that the %PD variable was computed
independently of a center’s case mix. For example, oneand its widespread adoption. Examples might include
the introduction of new technologies such as Y-set and renal center might give more emphasis to PD than a sec-
ond center. However, the second center might have adouble-bag systems, which reduce the risk of peritonitis,
the delivery of higher clearances and the more effective greater percentage of patients initiating dialysis on PD
because the first has a greater percentage of patients whosemanagement of infectious complications, volume status
and cardiovascular diseases. It is also possible that through health contra-indicates assignment to PD. Although ad-
justing the %PD variable was indeed an option, it wasexperience centers become more adept at identifying
appropriate patients to receive PD. Unfortunately, there not pursued due to concerns regarding interpretability.
That is, unadjusted percentages are more readily inter-are no data to evaluate the extent to which either of
these phenomena may underlie our results. Indeed, re- preted than adjusted odds ratios, particularly since the
latter would be measured with respect to an arbitrarilysults from this investigation are mostly of the hypothesis-
generating nature, providing a basis for more detailed selected reference center whose identity would not be
revealed.examination.
The cumulative PD patient count variable served to Previous investigations of the CORR database reported
significant decreases in PD mortality [11] and TF [12]quantify each renal center’s experience with PD. Patient-
specific data were only available from 1981 onward (that over calendar time. A lack of data on practice patterns
meant that the authors could only speculate on the fac-is, “registered patients”). Thus, we could not succeed in
enumerating every single patient who had actually re- tors that might be responsible for the decrease. A natural
hypothesis is that, as calendar time progresses, cliniciansceived PD at each center, since patients who initiated PD
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and centers practicing PD gain valuable experience with quite imprecise. Nonetheless, the discrepancy between
each patient treated, the cumulative effect of which is the covariate- and covariate/comorbidity-adjusted RRs
improvement in patient outcomes through the develop- can be used as an indicator of how results would be
ment and refinement of patient management strategies. changed upon incorporation of more precise comorbidity
A concern is that cumulative PD patient count is, natu- data (for example, severity index).
rally, a nondecreasing quantity as calendar time pro- Our investigation provides evidence that a renal cen-
gresses. Thus, the calendar time and PD count covariates ter’s experience with PD (measured by the cumulative
will exhibit positive correlation. However, the improve- number of PD patients treated) and degree of specializa-
ment associated with increased PD experience is not tion toward PD (measured by the percentage of patients
an artifact resulting from the correlation between PD initiating dialysis on PD) are strong predictors of out-
patient count and calendar time, since calendar time was comes after adjusting for known prognostic factors. Since
adjusted for in the current analysis. The question then pertinent data are unavailable, we are unable to assess
arises regarding how much of the improvement over time which specific factors, other than experience, are associ-
can be explained away by the PD experience effect. Our ated with improved PD outcomes. As such, future studies
results indicate that the PD patient count accounts for should examine the decreases in further detail to deter-
only a fraction of the calendar time effect. For example, mine which specific center clinical and operational char-
the adjusted mortality RR for the 1994 to 1997 calendar acteristics (for example, nurse:patient ratio) impact on
period (vs. 1981 to 1985), accounting for the cumulative mortality and TF rate reduction. Despite the value of
increase in PD patients (data not tabulated) is estimated registry data, this will entail data collection of much
at 0.71 (0.66, 0.77), compared with that not adjusting for greater detail than that typically available from CORR
PD count: RR  0.63 (0.58, 0.67) [11]. Thus, as one and other renal failure registries. Although an ambitious
might expect, the decrease in PD mortality over time is undertaking, information gained by such an effort will be
partly attributable to increased experience with the tech- of great value to the nephrology community, and ulti-
nique, resulting from the cumulative increase in the num- mately to patients who receive PD.
ber of PD patients treated. However, it cannot be attrib-
uted to this factor alone. Thus, advances in PD practices ACKNOWLEDGMENTS
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